An updated report from the Congressional Research Service proposes a series of questions to help inform and guide congressional debate on the future of the U.S. war in Afghanistan and its aftermath. See In Brief: Next Steps in the War in Afghanistan? Issues for Congress, June 15, 2012.
Other new and (mostly) updated CRS reports that Congress has not made publicly accessible include the following.
Navy Irregular Warfare and Counterterrorism Operations: Background and Issues for Congress, June 13, 2012
The Navy Biofuel Initiative Under the Defense Production Act, June 13, 2012
Navy Ship Names: Background For Congress, June 15, 2012
Navy Force Structure and Shipbuilding Plans: Background and Issues for Congress, June 14, 2012
Coast Guard Polar Icebreaker Modernization: Background, Issues, and Options for Congress, June 14, 2012
Coast Guard Cutter Procurement: Background and Issues for Congress, June 13, 2012
Employee Stock Options: Tax Treatment and Tax Issues, June 15, 2012
Proliferation Security Initiative (PSI), June 15, 2012
U.S. Response to the Global Threat of Malaria: Basic Facts, June 15, 2012
U.S. Response to the Global Threat of Tuberculosis: Basic Facts, June 15, 2012
U.S. Response to the Global Threat of HIV/AIDS: Basic Facts, June 15, 2012
U.S.-Taiwan Relationship: Overview of Policy Issues, June 15, 2012
Drought in the United States: Causes and Issues for Congress, June 12, 2012
With wildfire risk increasing and the potential for destruction along with it continues to grow nationwide, the Federation of American Scientists (FAS) today joins with other organizations to launch a new coalition, Partners in Wildfire Prevention.
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.